AI platform brings multiple oncology workflows together to support clinicians, hospitals and the future of precision cancer care
Medicas, the healthcare technology company behind Medicas Comprehensive Cancer Care (MC3), is advancing the use of artificial intelligence in oncology through Onco AI, an integrated AI platform designed specifically around the complex workflows of cancer care.
Rather than positioning AI as a standalone chatbot or documentation tool, Onco AI brings multiple oncology workflows together on a common intelligent platform, helping hospitals organize clinical information, support oncology workflows and build a more connected view of the patient.
The platform is already demonstrating practical benefits within hospital environments, helping teams explore how AI can reduce information burden, improve workflow efficiency and support more connected cancer care.
Built for the Complexity of Oncology
Cancer care generates enormous volumes of information across pathology, imaging, laboratory reports, treatment history, clinical notes, molecular and genomic data, and ongoing patient interactions.
Onco AI is being developed to bring these different information streams together and make them more usable across the oncology journey.
Its evolving capabilities span areas such as:
At the centre of the platform is the concept of a Living Digital Twin — an evolving, unified representation of the patient’s clinical journey that can support multiple oncology workflows rather than creating isolated AI applications for individual tasks.
From Clinical Vision to a Working Platform
A significant part of Onco AI’s development has been driven by clinicians who understand the realities of oncology from within the healthcare system.
Medicas extends its special appreciation to Dr. Hari Parameswaran and Dr. Naveen Yarlagadda for their role in shaping and engineering Onco AI from the ground up — bringing together clinical understanding, oncology workflows and technology to create a platform designed around the actual needs of cancer care.
Their contribution reflects an important principle behind Onco AI:
AI in oncology should be built around clinical workflows, not simply added to them.
Beyond Another AI Tool
The vision for Onco AI is to move beyond a collection of disconnected AI applications.
One Platform. Every Oncology Workflow. One Living Digital Twin.
As hospitals continue to evaluate practical applications of AI, Onco AI is being developed as an enterprise-level oncology platform that can evolve alongside clinical teams, hospital systems and the increasing complexity of cancer care.
Medicas is continuing to work with healthcare institutions to expand the platform’s capabilities and identify areas where AI can create measurable value for clinicians, hospitals and patients.
About Medicas
Medicas is a healthcare technology platform focused on making healthcare more accessible, connected and technology-enabled. Its oncology initiative, MC3 – Medicas Comprehensive Cancer Care, connects patients and treating physicians with international oncology expertise, second opinions, multidisciplinary perspectives and clinical trial navigation.
Through Onco AI, Medicas is extending this vision into the next generation of intelligent, connected oncology care.
Subscribe to our newsletter to receive the latest news, updates, and insights from EGS Health.
Subscribe Now